|Free Dividend Report|
|Stock Splits Calendar|
|ACHV Stock Split History|
|Preferred Stock Newsletter|
|Top Option Ideas|
|Stock Message Boards|
Achieve Life Science (ACHV) has 2 splits in our ACHV split history database. The first split for ACHV took place on August 03, 2017. This was a 1 for 11 reverse split, meaning for each 11 shares of ACHV owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 90.9090909090909 share position following the split. ACHV's second split took place on May 24, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of ACHV owned pre-split, the shareholder now owned 1 share. For example, a 90.9090909090909 share position pre-split, became a 9.09090909090909 share position following the split.
When a company such as Achieve Life Science conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ACHV split history from start to finish, an original position size of 1000 shares would have turned into 9.09090909090909 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Achieve Life Science shares, starting with a $10,000 purchase of ACHV, presented on a split-history-adjusted basis factoring in the complete ACHV split history.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-56.15%|
|About Achieve Life Science|
|Achieve Life Sciences is a clinical-stage pharmaceutical company engaged in the development and commercialization of cytisinicline for smoking cessation. Co.'s product candidate, Ccytisinicline is a smoking cessation aid that interacts with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms and the reward and satisfaction associated with smoking. Co. has a license and supply agreement with Sopharma, AD (Sopharma) for the development and commercialization of cytisinicline outside of Sopharma's territory, which consists of certain countries in Central and Eastern Europe, Scandinavia, North Africa, the Middle East and Central Asia, as well as Vietnam. According to our ACHV split history records, Achieve Life Science has had 2 splits.|
|ACHV Split History Table|
|08/03/2017||1 for 11|
|05/24/2018||1 for 10|
|Healthcare Stock Splits|
|ACHV is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
Also explore: ACHV shares outstanding history